NCM
SBIO icon

Niemann Capital Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Niemann Capital Management’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,740
Closed -$491K – 32
2020
Q2 		$491K Buy
+11,740
New +$463K 0.64% 20

Other funds holding SBIO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Niemann Capital Management's SBIO Position: Q3 2020 in Review

Niemann Capital Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2020, closing a stake of 11,740 shares — an estimated $491K sold.

Niemann Capital Management first reported a position in SBIO in Q2 2020 and held it in 1 quarter. The position peaked at $491K in Q2 2020. 52 funds tracked by Wall St. Rank hold SBIO as of Q3 2020.

  • Niemann Capital Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2020 after selling out during the quarter.
  • Niemann Capital Management sold 11,740 ALPS Medical Breakthroughs ETF shares in Q3 2020, an estimated $491K.
  • Niemann Capital Management first reported a position in ALPS Medical Breakthroughs ETF in Q2 2020 and held it in 1 quarter.
  • Niemann Capital Management's ALPS Medical Breakthroughs ETF position peaked at $491K in Q2 2020.
  • 52 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2020.

Based on Niemann Capital Management's 13F filing for Q3 2020, filed 10 Nov 2020.